Results for tag: "Hepatitis"

The Hepatitis market is a subset of the larger Hepatology market, which focuses on the diagnosis, treatment, and prevention of liver diseases. Hepatitis is a viral infection that can cause inflammation of the liver, and can be caused by a variety of viruses, including hepatitis A, B, C, D, and E. Treatment for hepatitis can include antiviral medications, immunosuppressants, and interferon therapy. Vaccines are also available to prevent hepatitis A and B. The Hepatitis market is a growing field, with a focus on developing new treatments and therapies to improve patient outcomes. Companies in the market include Gilead Sciences, AbbVie, Merck, Bristol-Myers Squibb, and Novartis. Show Less Read more